Health
Study reveals mechanisms behind sensitivity of multiple myeloma cells to EZH2 inhibition – News-Medical.net
Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma….
Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma. The reduction is caused by changes in the cancer cells’ metabolism. These changes can be used as markers to discriminate whether a patient would respond to treatment by EZH2 inhibition. The study has been published in the journal Cell Death & Disease.
Multiple myeloma is a type of blood cancer where immune cells grow in an uncontrolled…
-
Noosa News20 hours agoCareer Moves: WGC Lawyers – Proctor
-
Noosa News21 hours agoMan dies while restrained by security staff in Brisbane’s Fortitude Valley
-
Noosa News21 hours agoMan dies after dispute with security outside bar
-
General19 hours ago‘Aggro’ Dutton bagged as Libs fault Welcome to Country